Health Plans
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

OIG: Medicaid Paid $6.2B for Unapproved Drugs

John Commins, for HealthLeaders Media, November 30, 2010

OIG recommended that the FDA conduct frequent reviews of the NDC Directory to ensure its accuracy and thoroughness, and work with the Centers for Medicare & Medicaid Services and Congress to create legislative or regulatory changes that force drug makers to list all approved products with FDA before they're eligible for Medicaid payments.

In its formal response to the audit, FDA said it generally agreed with the OIG's recommendations, and had already begun implementing several initiatives to evaluate and enhance the quality of drug listing data.

See Also:

CMS Paid $112M for Potentially Harmful Drugs, OIG Says
OIG: Medicare Contractor Overpaid $39.2 Million for Diabetic's Supplies
OIG: Feds Paid $43.3 Million for Possibly Ineffective Drugs
OIG: Medicare Paid $1.2 Billion For Drugs With Invalid Prescriber Numbers


John Commins is a senior editor with HealthLeaders Media.

Comments are moderated. Please be patient.